Stericycle Rises On Unusually High Volume (SRCL)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Stericycle Incorporated (Nasdaq: SRCL) is trading at unusually high volume Monday with 823,263 shares changing hands. It is currently at 2.1 times its average daily volume and trading up $3.30 (+3.1%) at $109.71 as of 3:36 p.m. ET.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Stericycle has a market cap of $9.22 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 14.1% year to date as of the close of trading on Friday.

Stericycle, Inc., together with its subsidiaries, provides regulated waste management and related services. The company has a P/E ratio of 33.6, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Stericycle as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Stericycle Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

Exact Sciences, Cognizant Technology, MetLife: 'Mad Money' Lightning Round

Exact Sciences, Cognizant Technology, MetLife: 'Mad Money' Lightning Round

Sentiment Is Everything Right Now: Cramer's 'Mad Money' Recap (Thursday 11/2/17)

Sentiment Is Everything Right Now: Cramer's 'Mad Money' Recap (Thursday 11/2/17)

Discovering a True Value

Discovering a True Value

The Value of an Overvalued Market: Cramer's 'Mad Money' Recap (Thursday 8/10/17)

The Value of an Overvalued Market: Cramer's 'Mad Money' Recap (Thursday 8/10/17)

Wide Moat, Bargain Price

Wide Moat, Bargain Price